Evidence map›Paper›PMID 27261198›Full record

ArticleThe EMBO journal2016

DnaJ/Hsc70 chaperone complexes control the extracellular release of neurodegenerative-associated proteins.

Sarah N Fontaine, Dali Zheng, Jonathan J Sabbagh, Mackenzie D Martin, Dale Chaput, April Darling, Justin H Trotter, Andrew R Stothert, Bryce A Nordhues, April Lussier and 6 more

Abstract read
In one paragraph

Article in The EMBO journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 127 papers.

0numbers the graph read from it
0cells of the map it votes in
127citing papers in PubMed
14.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

127 citing papers in PubMed, 206 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. A J-domain protein enhances memory by promoting physiological amyloid formation inProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. DnaJB1 chaperone inhibits tau aggregation by recognizing its N-terminus.bioRxiv : the preprint server for biology · 2025
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Multimodal spatial gradients to explain regional susceptibility to fibrillar tau in Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  15. Targeted protein degradation with bifunctional molecules as a novel therapeutic modality for Alzheimer's disease & beyond.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

67 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Sarah N FontaineDepartment of Molecular Medicine, College of Medicine, Byrd Alzheimer's Institute, University of South Florida, Tampa, FL, USA James A. Haley Veteran's Hospital, Tampa, FL, USA sarah.fontaine@uky.edu cdickey@health.usf.edu.
Dali ZhengDepartment of Molecular Medicine, College of Medicine, Byrd Alzheimer's Institute, University of South Florida, Tampa, FL, USA.
Jonathan J SabbaghDepartment of Molecular Medicine, College of Medicine, Byrd Alzheimer's Institute, University of South Florida, Tampa, FL, USA James A. Haley Veteran's Hospital, Tampa, FL, USA.
Mackenzie D MartinDepartment of Molecular Medicine, College of Medicine, Byrd Alzheimer's Institute, University of South Florida, Tampa, FL, USA James A. Haley Veteran's Hospital, Tampa, FL, USA.
Dale ChaputDepartment of Cell, Molecular and Life Sciences, University of South Florida, Tampa, FL, USA.
April DarlingDepartment of Molecular Medicine, College of Medicine, Byrd Alzheimer's Institute, University of South Florida, Tampa, FL, USA.
Justin H TrotterDepartment of Molecular and Cellular Physiology, Stanford University, Stanford, CA, USA.
Andrew R StothertDepartment of Molecular Medicine, College of Medicine, Byrd Alzheimer's Institute, University of South Florida, Tampa, FL, USA.
Bryce A NordhuesDepartment of Molecular Medicine, College of Medicine, Byrd Alzheimer's Institute, University of South Florida, Tampa, FL, USA.
April LussierDepartment of Molecular Medicine, College of Medicine, Byrd Alzheimer's Institute, University of South Florida, Tampa, FL, USA.
Jeremy BakerDepartment of Molecular Medicine, College of Medicine, Byrd Alzheimer's Institute, University of South Florida, Tampa, FL, USA.
Lindsey SheltonDepartment of Molecular Medicine, College of Medicine, Byrd Alzheimer's Institute, University of South Florida, Tampa, FL, USA.
Mahnoor KahnDepartment of Molecular Medicine, College of Medicine, Byrd Alzheimer's Institute, University of South Florida, Tampa, FL, USA.
Laura J BlairDepartment of Molecular Medicine, College of Medicine, Byrd Alzheimer's Institute, University of South Florida, Tampa, FL, USA.
Stanley M StevensDepartment of Cell, Molecular and Life Sciences, University of South Florida, Tampa, FL, USA.
Chad A DickeyDepartment of Molecular Medicine, College of Medicine, Byrd Alzheimer's Institute, University of South Florida, Tampa, FL, USA James A. Haley Veteran's Hospital, Tampa, FL, USA sarah.fontaine@uky.edu cdickey@health.usf.edu.ORCID 0000-0003-3834-3159
University of South Florida · USStanford University · US

Funding

The Hsp90 cochaperone FKBP51 regulates tau structure and functionR01NS073899 · NINDS · UNIVERSITY OF SOUTH FLORIDA · PI Laura J Blair · 2011 to 2026
$6.9M
Hsp70_DNAJ interface as a drug target for Alzheimers disease and TBII01BX001637 · VA · JAMES A. HALEY VA MEDICAL CENTER · PI BICKFORD, PAULA C · 2013 to 2017
–
BLRD VA I01 BX001637NINDS NIH HHS R01 NS073899
6 · The paper itself

Abstract

It is now known that proteins associated with neurodegenerative disease can spread throughout the brain in a prionlike manner. However, the mechanisms regulating the trans-synaptic spread propagation, including the neuronal release of these proteins, remain unknown. The interaction of neurodegenerative disease-associated proteins with the molecular chaperone Hsc70 is well known, and we hypothesized that much like disaggregation, refolding, degradation, and even normal function, Hsc70 may dictate the extracellular fate of these proteins. Here, we show that several proteins, including TDP-43, α-synuclein, and the microtubule-associated protein tau, can be driven out of the cell by an Hsc70 co-chaperone, DnaJC5. In fact, DnaJC5 overexpression induced tau release in cells, neurons, and brain tissue, but only when activity of the chaperone Hsc70 was intact and when tau was able to associate with this chaperone. Moreover, release of tau from neurons was reduced in mice lacking the DnaJC5 gene and when the complement of DnaJs in the cell was altered. These results demonstrate that the dynamics of DnaJ/Hsc70 complexes are critically involved in the release of neurodegenerative disease proteins.

Indexed as

alpha-SynucleinCell LineDNA-Binding ProteinsHSC70 Heat-Shock ProteinsHSP40 Heat-Shock ProteinsHumansMembrane Proteinstau Proteinsalpha-Synucleincysteine string proteinDNA-Binding ProteinsHSC70 Heat-Shock ProteinsHSP40 Heat-Shock ProteinsHSPA8 protein, humanMembrane ProteinsTARDBP protein, humantau ProteinsDnaJextracellularHsc70neurodegenerationtau

Identifiers

PMID27261198
PMCPMC4946142
OpenAlexW2412227163

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.